研究成果 (51)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/6

A C D E F G H I J L M N P R S T V W 全部

What do oncologists need to know about biosimilar products?
Linda K. S. Leung, Kevin Mok, Calvin Liu, Stephen L. Chan ( 2016 )
Publication in refereed journal
典藏於此文庫的全文:
63884402.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1186/s40880-016-0151-x
Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies
Jou E, Gligich O, Chan ACY, Mohan D, Felsen UR, Ayyappan S, Billett HH, Hui EP, Chan ATC, Raghupathy R ( 2016 )
ANNALS OF HEMATOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00277-016-2588-z
Tumorigenesis of smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is related to its ability to stimulate thromboxane synthase and enhance stemness of non-small cell lung cancer stem cells
Liu Y, Yang SC, Li MY, Huang RY, Ng CSH, Wan IYP, Long X, Wu J, Wu B, Du J, Mok TSK, Underwood MJ, Chen GG ( 2016 )
CANCER LETTERS
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.canlet.2015.10.017
Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes
Yu SCH, Hui EP, Tang P, Chan SKC, Chu CCM, Hui JWY, Chan SL, Lee KF, Lai PBS, Yeo W ( 2016 )
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jvir.2015.11.032
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
Du ZF, Li LL, Huang X, Jin J, Huang SM, Zhang Q, Tao Q ( 2016 )
ONCOTARGET
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.18632/oncotarget.7822
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse
Chan AWH, Yu SN, Yu YH, Tong JHM, Wang L, Tin EKY, Chong CCN, Chan SL, Wong GLH, Wong VWS, Chan HLY, Lai PBS, To KF ( 2016 )
HISTOPATHOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1111/his.13029
State of the Art Antiemetic Therapy for Cancer Patients
Lau TKH, Yip CHW, Yeo W ( 2016 )
CURRENT ONCOLOGY REPORTS
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s11912-015-0486-5
Single-Port Video-Assisted Thoracoscopic Major Lung Resections: Experience with 150 Consecutive Cases
Ng CSH, Kim HK, Wong RHL, Yim APC, Mok TSK, Choi YH ( 2016 )
THORACIC AND CARDIOVASCULAR SURGEON
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1055/s-0034-1396789
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Berhane S, Toyoda H, Tada T, Kumada T, Kagebayashi C, Satomura S, Schweitzer N, Vogel A, Manns MP, Benckert J, Berg T, Ebker M, Best J, Dechene A, Gerken G, Schlaak JF, Weinmann A, Worns MA, Galle P, Yeo W, Mo F, Chan SL, Reeves H, Cox T, Johnson P ( 2016 )
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.cgh.2015.12.042
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
Cheng AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, Yang TS, Wu CC, Chao Y, Chan SL, Kudo M, Ikeda M, Kang YK, Pan HM, Numata K, Han GH, Balsara B, Zhang Y, Rodriguez AM, Zhang Y, Wang YY, Poon RTP ( 2016 )
HEPATOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1002/hep.28600

10 | 25 | 50 | 100

1/6

研究成果 (51)

分享連結

Our policy towards the use of cookies